Psychedelics Break New Ground in Clinical Trials, Research to be Bolstered by Key FDA Guidance
![](https://www.mcalindenresearchpartners.com/wp-content/uploads/2023/07/pawel-czerwinski-dWFmRv6noU8-unsplash-1024x683.jpg)
New FDA guidance meant to steer clinical trials of psychedelic compounds will play a major role in the eventual approval…
McAlinden Research PartnersJuly 12, 2023